2019 Photomicrography Competition

Blood vessels of a murine (mouse) heart following myocardial infarction (heart attack)

Dr. Simon Frederik Merz Dr. Lea Bornemann, Sebastian Korste

Affiliation
University Hospital Essen
Institute for Experimental Immunology & Imaging
Essen, Nordrhein-Westfalen, Germany
Technique
Tissue Clearing, Light Sheet Fluorescence Microscopy
Magnifaction
2x (Objective Lens Magnification)

In Their Own Words

A Q&A with Nikon Small World winner Simon Merz.

What is the subject matter of your winning image and why did you choose this image?

The blood vessel system (mainly arteries) of a whole murine heart after an induced heart attack. Raw data were algorithm-enhanced to achieve better contrast. I am working towards the introduction of this technique in routine clinical diagnostics and for some tests we obtain proof of principle of our protocols using animal tissues before we can work with human material. The protocol used to clear this sample was later developed into a technique to clear and analyze a metastatic human lymph node. This image is a great example of what can be done with light-sheet fluorescence 3-D microscopy in combination with tissue clearing, giving an overview of the complex organ structure. It shows a whole mouse heart with high resolution, providing an easy-to-grasp and new perspective on the body.

What are the special techniques and/or challenges faced in creating this photomicrograph?

The challenge here lies in the clearing process before imaging. The sample needs to be translucent, so light can pass through it without being scattered to a high degree. Therefore, we have to change the composition of the tissue to homogenize the refractive index of all components within the sample. This, in combination with fluorophore-labeled antibodies against blood vessels, allows an in-depth analysis of the entire specimen. However, the obtained information is so dense that showing a 2-D representation of the 3-D data stack of about 6 mm tissue depth would result in a chaotic image. Therefore, algorithms are developed to clear images of distracting information, enhancing structural details that are relevant and allowing to focus on specific structures.

What is your primary line of work?

I am a Ph.D. student in the field of medical biology. I work on the implementation of novel 3-D microscopy in routine cancer diagnostics, mainly in the field of melanoma.

How long have you been taking photographs through a microscope? What first sparked your interest in photomicrography?

Since 2012, during my bachelor studies in Heidelberg, Germany. I started with simple nuclear staining. Typically, to study what happens inside a cell, an organ or body, we have to utterly destroy the complex three-dimensional structure to obtain a readout. Photomicrography gives us the chance to look at cells or whole organs with sometimes minimal changes. Microscopy, specifically light-sheet microscopy, is a beautiful way to see and understand how things fit together in a spatial and structural way on a larger scale.

Do you tend to focus your microscopy toward a specific subject matter or theme? If so, why?

I am mainly interested in light-sheet fluorescence microscopy. It is fascinating to help people move away from the typical slice-derived 2-D analyses towards 3-D visualization of structures, organs and their complexity. This 3rd dimension sparks a lot of new ideas and perspectives. However, displaying it, especially in printed versions, can sometimes be very difficult. Therefore, algorithm-enhancements and subsequent 2-D displays are necessary to deliver the contents to an audience that is still used to read in 2-D.

Why did you enter the Nikon Small World Photomicrography competition? What do you think of the competition?

I see this competition as a great way to deliver the beauty of nature to people and simultaneously highlight the importance of science and the work behind it. I would like to make people aware of light-sheet fluorescence microscopy 3-D imaging and want to contribute to a rapidly growing field that has started to have clinical applications.